Nucleus_Commercial_Financ - Accounts


Nucleus Commercial Finance Limited
Annual Report and Financial Statements
For the year ended 31 March 2022
Company Registration No. 07829566 (England and Wales)
Nucleus Commercial Finance Limited
Company Information
Directors
C Shah
M Goldman
S Willmett
Secretary
G May
Company number
07829566
Registered office
Mezzanine Floor
St Albans House
57-59 Haymarket
London
SW1Y 4QX
Auditor
Moore Kingston Smith LLP
6th Floor
9 Appold Street
London
EC2A 2AP
Nucleus Commercial Finance Limited
Contents
Page
Directors' report
1 - 2
Independent auditor's report
3 - 6
Profit and loss account
7
Balance sheet
8
Statement of changes in equity
9
Notes to the financial statements
10 - 14
Nucleus Commercial Finance Limited
Directors' Report
For the year ended 31 March 2022
Page 1

The directors present their annual report and financial statements for the year ended 31 March 2022.

Principal activities

The principal activity of the company continued to be the provision of invoice factoring.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

C Shah
M Goldman
S Willmett
Auditor

The auditor, Moore Kingston Smith LLP, is deemed to be reappointed under section 487(2) of the Companies Act 2006.

Statement of directors' responsibilities

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

 

  •     select suitable accounting policies and then apply them consistently;

  •     make judgements and accounting estimates that are reasonable and prudent;

  •     state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements;

  •     prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Nucleus Commercial Finance Limited
Directors' Report (Continued)
For the year ended 31 March 2022
Page 2
Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

On behalf of the board
S Willmett
Director
30 September 2022
Nucleus Commercial Finance Limited
Independent Auditor's Report
To the Members of Nucleus Commercial Finance Limited
Page 3
Opinion

We have audited the financial statements of Nucleus Commercial Finance Limited (the 'company') for the year ended 31 March 2022 which comprise the Profit and Loss Account, the Balance Sheet, the Statement of Changes in Equity and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

  •     give a true and fair view of the state of the company's affairs as at 31 March 2022 and of its profit for the year then ended;

  •     have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

  •     have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report, other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

 

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Nucleus Commercial Finance Limited
Independent Auditor's Report (Continued)
To the Members of Nucleus Commercial Finance Limited
Page 4

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

  • the information given in the Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

  • the Directors' Report has been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Directors' Report.

 

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

 

  •     adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

  •     the financial statements are not in agreement with the accounting records and returns; or

  •     certain disclosures of remuneration specified by law are not made; or

  •     we have not received all the information and explanations we require for our audit; or

  •     the directors were not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the small companies' exemption in preparing the Directors' Report and take advantage of the small companies exemption from the requirement to prepare a Strategic Report.

Responsibilities of directors

As explained more fully in the Directors' Responsibilities Statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

 

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Nucleus Commercial Finance Limited
Independent Auditor's Report (Continued)
To the Members of Nucleus Commercial Finance Limited
Page 5
Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

 

As part of an audit in accordance with ISAs (UK) we exercise professional judgement and maintain professional scepticism throughout the audit. We also:

 

  • Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

  • Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purposes of expressing an opinion on the effectiveness of the company’s internal control.

  • Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the directors.

  • Conclude on the appropriateness of the directors’ use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the company’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the company to cease to continue as a going concern.

  • Evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that achieves fair presentation.

 

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

 

Nucleus Commercial Finance Limited
Independent Auditor's Report (Continued)
To the Members of Nucleus Commercial Finance Limited
Page 6

Explanation as to what extent the audit was considered capable of detecting irregularities, including fraud

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below.

The objectives of our audit in respect of fraud, are; to identify and assess the risks of material misstatement of the financial statements due to fraud; to obtain sufficient appropriate audit evidence regarding the assessed risks of material misstatement due to fraud, through designing and implementing appropriate responses to those assessed risks; and to respond appropriately to instances of fraud or suspected fraud identified during the audit. However, the primary responsibility for the prevention and detection of fraud rests with both management and those charged with governance of the company.

Our approach was as follows:

 

  • We obtained an understanding of the legal and regulatory requirements applicable to the company and considered that the most significant are the Companies Act 2006, UK financial reporting standards as issued by the Financial Reporting Council, and UK taxation legislation.

  • We obtained an understanding of how the company complies with these requirements by discussions with management and those charged with governance.

  • We assessed the risk of material misstatement of the financial statements, including the risk of material misstatement due to fraud and how it might occur, by holding discussions with management and those charged with governance.

  • We inquired of management and those charged with governance as to any known instances of non-compliance or suspected non-compliance with laws and regulations.

  • Based on this understanding, we designed specific appropriate audit procedures to identify instances of non-compliance with laws and regulations. This included making enquiries of management and those charged with governance and obtaining additional corroborative evidence as required.

 

There are inherent limitations in the audit procedures described above. We are less likely to become aware of instances of non-compliance with laws and regulations that are not closely related to events and transactions reflected in the financial statements. Also, the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery or intentional misrepresentations, or through collusion.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members, as a body, for our audit work, for this report, or for the opinions we have formed.

Ryan Day (Senior Statutory Auditor)
for and on behalf of Moore Kingston Smith LLP
30 September 2022
Chartered Accountants
Statutory Auditor
6th Floor
9 Appold Street
London
EC2A 2AP
Nucleus Commercial Finance Limited
Profit and Loss Account
For the year ended 31 March 2022
Page 7
2022
2021
£
£
Turnover
3,139,757
1,953,963
Cost of sales
(292,692)
(173,628)
Gross profit
2,847,065
1,780,335
Administrative expenses
(1,000,906)
(318,814)
Operating profit
1,846,159
1,461,521
Interest payable and similar expenses
(678,181)
(1,175,170)
Profit before taxation
1,167,978
286,351
Taxation
-
0
-
0
Profit for the financial year
1,167,978
286,351
Total comprehensive income for the year
1,167,978
286,351
Nucleus Commercial Finance Limited
Balance Sheet
As at 31 March 2022
Page 8
2022
2021
Notes
£
£
£
£
Fixed assets
Investments
4
1
-
0
Current assets
Debtors
6
5,934,223
6,922,491
Cash at bank and in hand
4,954,747
4,838,643
10,888,970
11,761,134
Creditors: amounts falling due within one year
7
(4,008,635)
(5,548,776)
Net current assets
6,880,335
6,212,358
Total assets less current liabilities
6,880,336
6,212,358
Creditors: amounts falling due after more than one year
8
(5,462,906)
(5,462,906)
Net assets
1,417,430
749,452
Capital and reserves
Called up share capital
9
100,000
100,000
Profit and loss reserves
1,317,430
649,452
Total equity
1,417,430
749,452

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 30 September 2022 and are signed on its behalf by:
S Willmett
Director
Company Registration No. 07829566
Nucleus Commercial Finance Limited
Statement of Changes in Equity
For the year ended 31 March 2022
Page 9
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 April 2020
100,000
1,363,101
1,463,101
Year ended 31 March 2021:
Profit and total comprehensive income for the year
-
286,351
286,351
Dividends
-
(1,000,000)
(1,000,000)
Balance at 31 March 2021
100,000
649,452
749,452
Year ended 31 March 2022:
Profit and total comprehensive income for the year
-
1,167,978
1,167,978
Dividends
-
(500,000)
(500,000)
Balance at 31 March 2022
100,000
1,317,430
1,417,430
Nucleus Commercial Finance Limited
Notes to the Financial Statements
For the year ended 31 March 2022
Page 10
1
Accounting policies
Company information

Nucleus Commercial Finance Limited is a private company limited by shares domiciled and incorporated in England and Wales. The registered office is Mezzanine Floor, St Albans House, 57-59 Haymarket, London, SW1Y 4QX.

1.1
Accounting convention

These financial statements have been prepared in accordance with Section 1A of FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Exemptions for qualifying entities under FRS 102

This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:

 

  • Section 7 ‘Statement of Cash Flows’: Presentation of a statement of cash flow and related notes and disclosures;

  • Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instrument Issues: Interest income/expense and net gains/losses for financial instruments not measured at fair value; basis of determining fair values; details of collateral, loan defaults or breaches, details of hedges, hedging fair value changes recognised in profit or loss and in other comprehensive income;

  • Section 33 ‘Related Party Disclosures’: Compensation for key management personnel.

 

The financial statements of the company are consolidated in the financial statements of Nucleus Commercial Holdings Limited. These consolidated financial statements are available from its registered office, Mezzanine Floor, St Albans House, 57-59 Haymarket, London, SW1Y 4QX.

Nucleus Commercial Finance Limited
Notes to the Financial Statements (Continued)
For the year ended 31 March 2022
1
Accounting policies
(Continued)
Page 11
1.3
Going concern

As at 31 March 2022, the company had net assets of £1,417,430 and made a profit of £1,167,978 for the year ended 31 March 2022. The company is a subsidiary of Nucleus Commercial Holdings Limited. The group is funded through long-term credit facilities with third party lenders and the amount owed at 31 March 2022 was £293,351,083.true

 

In March 2020, the World Health Organization declared the outbreak of a novel coronavirus (COVID-19) as a global health pandemic, which spread throughout the UK. The directors have continued to monitor the situation throughout the year ended 31 March 2022 and beyond.

 

In April 2021, Nucleus Cash Flow Finance4 Limited the Group became accredited by the BBB to be an RLS lender and as of 31 March 2022, the group had paid out approximately £100m in new loans. The Directors expect that there will be sufficient profits made from servicing fees and interest receivable on the RLS loans, as well as profits made from the other profitable entities in the group to continue to support the loss-making entities within the group, for at least one year from the date of approval of the accounts, even in the event of a high rate of borrowers defaulting. As such the accounts have been prepared on a going concern basis.

1.4
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business, and is shown net of VAT. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Factoring charge revenue is recognised monthly dependent on the value of the client's facility. Take on fees are accrued at the point of the start of the contract with the client. Commitment fees relate to preliminary work carried out to establish the risk profile of the client which are then recharged and are accrued as invoiced. Early exit fees are recognised upon the early termination of a contract. As such there is no material revenue which is subject to the stage of completion of a contract.

1.5
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

1.6
Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks and other short-term liquid investments with original maturities of three months or less.

1.7
Financial instruments

Basic financial instruments are measured at cost. The company has no other financial instruments or basic financial instruments measured at fair value.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

Nucleus Commercial Finance Limited
Notes to the Financial Statements (Continued)
For the year ended 31 March 2022
1
Accounting policies
(Continued)
Page 12

Changes in the fair value of derivatives that are designated and qualify as fair value hedges are recognised in profit or loss immediately, together with any changes in the fair value of the hedged asset or liability that are attributable to the hedged risk.

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.9
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Key sources of estimation uncertainty

The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows.

Bad debt provision

The company makes an estimate of the recoverable value of trade and other debtors. When assessing impairment of trade and other debtors, management considers factors including the current valuation of the assets that the company has security on, the ageing profile of debtors and historical experience. See Note 6 for the net carrying amount of the debtors and associated impairment provision.

3
Employees

There were no persons employed by the company during the year or the comparative period.

Nucleus Commercial Finance Limited
Notes to the Financial Statements (Continued)
For the year ended 31 March 2022
Page 13
4
Fixed asset investments
2022
2021
£
£
Shares in group undertakings and participating interests
1
-
0
Movements in fixed asset investments
Shares in subsidiaries
£
Cost or valuation
At 1 April 2021
-
Additions
1
At 31 March 2022
1
Carrying amount
At 31 March 2022
1
At 31 March 2021
-
5
Subsidiaries

These financial statements are separate company financial statements for Nucleus Commercial Finance Limited.

Details of the company's subsidiaries at 31 March 2022 are as follows:

Name of undertaking
Registered office
Class of
% Held
shares held
Direct
Trafalgar Auditors Limited
Mezzanine Floor, St Albans House, 57-59 Haymarket, London, SW1Y 4QX
Ordinary
100.00
6
Debtors
2022
2021
Amounts falling due within one year:
£
£
Trade debtors
5,399,213
6,296,183
Corporation tax recoverable
-
0
76,523
Amounts due from group undertakings
535,010
549,785
5,934,223
6,922,491

Included within trade debtors is an amount of £96,090 (2021: £730,562) which is due after more than one year, gross of the bad debt provision.

Nucleus Commercial Finance Limited
Notes to the Financial Statements (Continued)
For the year ended 31 March 2022
Page 14
7
Creditors: amounts falling due within one year
2022
2021
£
£
Trade creditors
3,786,217
2,072,289
Amounts owed to group undertakings
68,317
17,844
Taxation and social security
73,384
96,970
Other creditors
80,717
3,361,673
4,008,635
5,548,776

Included in other creditors falling due within one year is £nil (2021: £3,249,342) loan secured by fixed and floating charges over the company's current assets.

8
Creditors: amounts falling due after more than one year
2022
2021
£
£
Other creditors
5,462,906
5,462,906

Included in other creditors due after more than one year is £5,462,906 (2021: £5,462,906) loan secured by fixed and floating charges over the company's current assets.

9
Called up share capital
2022
2021
£
£
Ordinary share capital
Issued and fully paid
10,000,000 Ordinary shares of 1p each
100,000
100,000
100,000
100,000
10
Related party transactions

The company has taken advantage of the exemption available in accordance with FRS 102 section 33 'Related Party Disclosures' not to disclose transactions entered into between two or more members of a group, as the company is a wholly owned subsidiary undertaking of the group with which it is party to the transactions.

11
Control

The parent company of Nucleus Commercial Finance Limited is Nucleus Commercial Holdings Limited, a company incorporated in England and Wales who prepare consolidated accounts for the group. Copies of the consolidated accounts are available from Mezzanine Floor, St Albans House, 57-59 Haymarket, London, SW1Y 4QX.

 

The ultimate parent undertaking is Nucleus Holdings Limited, a company incorporated in Isle of Man.

2022-03-312021-04-01falseCCH SoftwareCCH Accounts Production 2022.100C ShahM GoldmanS WillmettG May0078295662021-04-012022-03-3107829566bus:Director12021-04-012022-03-3107829566bus:Director62021-04-012022-03-3107829566bus:Director82021-04-012022-03-3107829566bus:CompanySecretary12021-04-012022-03-3107829566bus:Director22021-04-012022-03-3107829566bus:Director32021-04-012022-03-31078295662022-03-31078295662020-04-012021-03-3107829566core:RetainedEarningsAccumulatedLosses2020-04-012021-03-3107829566core:RetainedEarningsAccumulatedLosses2021-04-012022-03-31078295662021-03-3107829566core:CurrentFinancialInstrumentscore:WithinOneYear2022-03-3107829566core:CurrentFinancialInstrumentscore:WithinOneYear2021-03-3107829566core:Non-currentFinancialInstrumentscore:AfterOneYear2022-03-3107829566core:Non-currentFinancialInstrumentscore:AfterOneYear2021-03-3107829566core:CurrentFinancialInstruments2022-03-3107829566core:CurrentFinancialInstruments2021-03-3107829566core:ShareCapital2022-03-3107829566core:ShareCapital2021-03-3107829566core:RetainedEarningsAccumulatedLosses2022-03-3107829566core:RetainedEarningsAccumulatedLosses2021-03-3107829566core:ShareCapital2020-03-3107829566core:RetainedEarningsAccumulatedLosses2020-03-31078295662020-03-3107829566core:ShareCapitalOrdinaryShares2022-03-3107829566core:ShareCapitalOrdinaryShares2021-03-3107829566core:Subsidiary12021-04-012022-03-3107829566core:Subsidiary112021-04-012022-03-3107829566core:Non-currentFinancialInstruments2022-03-3107829566core:Non-currentFinancialInstruments2021-03-3107829566bus:OrdinaryShareClass12021-04-012022-03-3107829566bus:OrdinaryShareClass12022-03-3107829566bus:PrivateLimitedCompanyLtd2021-04-012022-03-3107829566bus:FRS1022021-04-012022-03-3107829566bus:Audited2021-04-012022-03-3107829566bus:FullAccounts2021-04-012022-03-31xbrli:purexbrli:sharesiso4217:GBP